NCT02904304View on ClinicalTrials.gov

Desloratadine,Phenylephrine Hcl,Ibuprofen Compared to Placebo in Treatment of Symptoms Associated With Common Cold/Flu

PHASE3SuspendedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

December 31, 2020

Primary Completion Date

July 31, 2021

Study Completion Date

September 30, 2021

Conditions
Cold
Interventions
DRUG

Desloratadine+Phenylephrine+Ibuprofen

01 tablet, orally, every 12 hours.

DRUG

Placebo

01 tablet, orally, every 12 hours.

Trial Locations (1)

Unknown

Allergisa Pesquisa Dermato Cosmética Ltda., Campinas

Sponsors
All Listed Sponsors
lead

Ache Laboratorios Farmaceuticos S.A.

INDUSTRY